LH Measurement Is Not Required in Initial Evaluation
LH measurement has limited diagnostic utility in the initial evaluation of irregular menstrual cycles in a 45-year-old woman because at least one-third of women with PCOS—the most common cause of menstrual irregularity—do not demonstrate an elevated LH or elevated LH/FSH ratio, making it an unreliable diagnostic marker. 1
Why LH Testing Has Limited Value
The American Association of Clinical Endocrinologists explicitly states that "the usefulness of a high LH level or an elevated LH/FSH ratio (>2.5) in diagnosing the presence of polycystic ovarian state in women with hyperandrogenism is limited, inasmuch as at least a third of the patients with PCOS do not demonstrate this abnormality" 1. This poor sensitivity makes LH measurement a suboptimal screening tool.
What Should Be Measured Instead
The initial hormonal evaluation should prioritize:
- Testosterone (total or free) - directly assesses hyperandrogenism, the hallmark of PCOS 2
- Mid-luteal progesterone (<6 nmol/l indicates anovulation) - confirms ovulatory dysfunction 2
- TSH and prolactin - rules out thyroid dysfunction and hyperprolactinemia 3
- FSH - if elevated (>35 IU/L), suggests ovarian insufficiency rather than PCOS 2
These tests provide more actionable diagnostic information than LH alone.
When LH Measurement May Be Considered
LH testing can be reserved for secondary evaluation when:
- Initial workup suggests PCOS and you need additional supportive evidence
- Assessing reproductive function specifically, as elevated LH is associated with poor ovulation induction response and increased miscarriage risk 1
- The diagnosis remains unclear after initial testing
Age-Specific Considerations
At age 45, this patient is approaching perimenopause. FSH becomes more diagnostically valuable than LH in this age group, as FSH rises significantly from age 39 onward (approximately 3-fold by ages 48-50), while LH changes minimally 4. An elevated FSH with low estradiol would indicate impending ovarian insufficiency rather than PCOS, fundamentally changing management.
The Clinical Algorithm
- First-line tests: Testosterone, mid-luteal progesterone, TSH, prolactin, FSH
- If testosterone elevated + progesterone low: Likely PCOS—proceed with metabolic screening (glucose/insulin, lipids) and pelvic ultrasound 2
- If FSH elevated (>35 IU/L): Likely ovarian insufficiency—LH measurement adds no value
- Only if diagnosis unclear: Consider adding LH to assess LH/FSH ratio
The key pitfall: Ordering LH reflexively without understanding its poor sensitivity leads to false reassurance when normal, potentially delaying diagnosis and treatment of PCOS and its metabolic consequences (insulin resistance, diabetes, cardiovascular disease) 1.